Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species
Anna Dudakova, Birgit Spieß, Marut Tangwattanachuleeporn, et al.
Clinical Microbiology Reviews (2017) Vol. 30, Iss. 4, pp. 1065-1091
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Aspergillus fumigatus and Aspergillosis in 2019
Jean‐Paul Latgé, Georgios Chamilos
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 864
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Amir Arastehfar, Toni Gabaldón, Rocio Garcia‐Rubio, et al.
Antibiotics (2020) Vol. 9, Iss. 12, pp. 877-877
Open Access | Times Cited: 212
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
Pieter P. A. Lestrade, Jacques F. Meis, Willem J. G. Melchers, et al.
Clinical Microbiology and Infection (2018) Vol. 25, Iss. 7, pp. 799-806
Open Access | Times Cited: 165
Aspergillus fumigatusand aspergillosis: From basics to clinics
Amir Arastehfar, Agostinho Carvalho, Jos Houbraken, et al.
Studies in Mycology (2021) Vol. 100, Iss. 1, pp. 100115-100115
Open Access | Times Cited: 165
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?
Sarah Kidd, Sharon C.‐A. Chen, Wieland Meyer, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 143
Azole resistance mechanisms in Aspergillus: update and recent advances
Alba Pérez‐Cantero, Loida López‐Fernández, Josep Guarro, et al.
International Journal of Antimicrobial Agents (2019) Vol. 55, Iss. 1, pp. 105807-105807
Closed Access | Times Cited: 141
Responding to the Emergence of Antifungal Drug Resistance: Perspectives from the Bench and the Bedside
Justin Beardsley, Catriona Halliday, Sharon C.‐A. Chen, et al.
Future Microbiology (2018) Vol. 13, Iss. 10, pp. 1175-1191
Open Access | Times Cited: 114
Organophotoredox-Catalyzed Direct C–H Amination of 2H-Indazoles with Amines
Sukanya Neogi, Asim Kumar Ghosh, Koushik Majhi, et al.
Organic Letters (2020) Vol. 22, Iss. 14, pp. 5605-5609
Closed Access | Times Cited: 76
Rapid Genomic Diagnosis of Fungal Infections in the Age of Next-Generation Sequencing
Chi‐Ching Tsang, Jade L. L. Teng, Susanna K. P. Lau, et al.
Journal of Fungi (2021) Vol. 7, Iss. 8, pp. 636-636
Open Access | Times Cited: 56
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 8, pp. 2053-2073
Open Access | Times Cited: 55
Genomic and Phenotypic Heterogeneity of Clinical Isolates of the Human Pathogens Aspergillus fumigatus, Aspergillus lentulus, and Aspergillus fumigatiaffinis
Renato Santos, Jacob L. Steenwyk, Olga Rivero-Menéndez, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 57
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance
Jochem B. Buil, Jason D. Oliver, Derek Law, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 703-714
Open Access | Times Cited: 35
The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Ilan S. Schwartz, Thomas F. Patterson
Current Infectious Disease Reports (2018) Vol. 20, Iss. 3
Closed Access | Times Cited: 52
Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
Jochem B. Buil, Ferry Hagen, Anuradha Chowdhary, et al.
Journal of Fungi (2018) Vol. 4, Iss. 3, pp. 103-103
Open Access | Times Cited: 49
Susceptibility Testing of Fungi to Antifungal Drugs
Maurizio Sanguinetti, Brunella Posteraro
Journal of Fungi (2018) Vol. 4, Iss. 3, pp. 110-110
Open Access | Times Cited: 47
Fungi in a One Health Perspective
Daniela Simões, Eugénia de Andrade, Raquel Sabino
Encyclopedia (2023) Vol. 3, Iss. 3, pp. 900-918
Open Access | Times Cited: 15
Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe
Maria Antonia De Francesco
Pathogens (2023) Vol. 12, Iss. 11, pp. 1305-1305
Open Access | Times Cited: 15
Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region
Ayate Zakaria, Marwan Osman, Fouad Dabboussi, et al.
Journal of Infection and Public Health (2019) Vol. 13, Iss. 1, pp. 1-10
Open Access | Times Cited: 40
Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States
Kizee A. Etienne, Elizabeth L. Berkow, Lalitha Gade, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 28
Examination of Genome-Wide Ortholog Variation in Clinical and Environmental Isolates of the Fungal Pathogen Aspergillus fumigatus
Maria Augusta Crivelente Horta, Jacob L. Steenwyk, Matthew E. Mead, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 19
Epidemiology and Azole Resistance of Clinical Isolates of Aspergillus fumigatus from a Large Tertiary Hospital in Ningxia, China
Yuting Kang, Qiujie Li, Yao Yao, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 427-439
Open Access | Times Cited: 4
Synergistic Antifungal Activity of PIT and ITZ Against Varied Aspergillus Species via Affecting The Ergosterol Content and Intracellular Drug Retention
Renhui Cai, Cong He, Qingtao Kong, et al.
Current Microbiology (2025) Vol. 82, Iss. 5
Closed Access
Cyp51A Dysfunction Leads to Higher Susceptibility to Azoles Including Fluconazole in Aspergillus fumigatus
Hidetaka Majima, Teppei Arai, Naoto Maruguchi, et al.
Mycoses (2025) Vol. 68, Iss. 4
Closed Access
The Dual Pathogen Fusarium: Diseases, Incidence, Azole Resistance, and Biofilms
Dongmei Li, Kincer Amburgey-Crovetti, Emilie Applebach, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 294-294
Open Access
Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates
Jessica Talbot, Shradha Subedi, Catriona Halliday, et al.
Journal of Antimicrobial Chemotherapy (2018) Vol. 73, Iss. 9, pp. 2347-2351
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top